The University of Southampton
University of Southampton Institutional Repository

Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD1)

Smith, W.C.S., Anderson, A.M., Withington, S.G., Croft, R.P., van Brakel, W.H., Nicholls, P.G. and Richardus, J.H. (2004) Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD1) BMJ, 328, (1459), pp. 1459-1464. (doi:10.1136/bmj.38107.645926.AE).

Record type: Article

Abstract

Objective: To determine whether addition of low dose prednisolone to multidrug treatment can prevent reaction and nerve function impairment in leprosy.
Design: Multicentre, double blind, randomised, placebo controlled, parallel group trial.
Setting: Six centres in Bangladesh and Nepal.
Participants: 636 people with newly diagnosed multibacillary leprosy.
Intervention: Prednisolone 20 mg/day for three months, with tapering dose in month 4, plus multidrug treatment, compared with multidrug treatment alone.
Main outcome measures: Signs of reaction, impairment of sensory and motor nerve function, and nerve tenderness needing full dose prednisolone at four months and one year.
Results: Prednisolone had a significant effect in the prevention of reaction and nerve function impairment at four months (relative risk 3.9, 95% confidence interval 2.1 to 7.3), but this was not maintained at one year (relative risk 1.3, 0.9 to 1.8). Fewer events occurred in the prednisolone group at all time points up to 12 months, but the difference at 12 months was small. Subgroup analysis showed a difference in response between people with and without impairment of nerve function at diagnosis.
Conclusions: The use of low dose prophylactic prednisolone during the first four months of multidrug treatment for leprosy reduces the incidence of new reactions and nerve function impairment in the short term, but the effect is not sustained at one year. The presence of nerve function impairment at diagnosis may influence the response to low dose prednisolone.

Full text not available from this repository.

More information

Published date: May 2004
Keywords: steroid prophylaxis, prevention of nerve function impairment, leprosy, TRIPOD 1

Identifiers

Local EPrints ID: 19207
URI: http://eprints.soton.ac.uk/id/eprint/19207
ISSN: 0959-8138
PURE UUID: fec1ff68-c2d6-45a4-bf4c-506bbfb53400

Catalogue record

Date deposited: 31 Jan 2006
Last modified: 17 Jul 2017 16:33

Export record

Altmetrics

Contributors

Author: W.C.S. Smith
Author: A.M. Anderson
Author: S.G. Withington
Author: R.P. Croft
Author: W.H. van Brakel
Author: P.G. Nicholls
Author: J.H. Richardus

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×